Methyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)picolinate

Catalog No. :
ACZGNI397
CAS No. :
1262197-81-8
Molecular Formula :
C12H13N3O3
Molecular Weight :
247.25

IUPAC Name:methyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)picolinate

Methyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)picolinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$359.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)picolinate
IUPAC Namemethyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)picolinate
MDL No.MFCD26936352
Molecular FormulaC12H13N3O3
Molecular Weight247.25
SMILESO=C(C1=NC(OC)=C(N2C=C(C)N=C2)C=C1)OC
InChI KeyPWFBGUZQQMGJRT-UHFFFAOYSA-N
SynonymMethyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridine-2-carboxylate;methyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)picolinate;2-Pyridinecarboxylic acid, 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-, methyl ester
CAS No.1262197-81-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZGNI397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAWXF524 route compound structure diagram
    ACAWXF5241214329-07-3 In Stock
  2. Plus
  3. ACWEOL817 route compound structure diagram
    ACWEOL817928113-28-4 In Stock
  4. Then
  5. ACZGNI397 route product structure diagram
    ACZGNI3971262197-81-8
Inquiry

2. ACZGNI397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWEOL817 route compound structure diagram
    ACWEOL817928113-28-4 In Stock
  4. Then
  5. ACZGNI397 route product structure diagram
    ACZGNI3971262197-81-8
Inquiry

Comments (0)